Glenmede Trust’s Puma Biotechnology PBYI Stock Holding History

Glenmede Trust’s Portfolio PBYI Stock Details PBYI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-928	Closed	-$9K	–	1946
2020 Q3	$9K	Hold	928	–	–	﹤0.01%	1921
2020 Q2	$9K	Sell	928 -826	-47%	-$8.55K	﹤0.01%	1917
2020 Q1	$15K	Hold	1,754	–	–	﹤0.01%	2233
2019 Q4	$15K	Hold	1,754	–	–	﹤0.01%	2233
2019 Q3	$18K	Sell	1,754 -100	-5%	-$1.08K	﹤0.01%	2096
2019 Q2	$23K	Hold	1,854	–	–	﹤0.01%	2011
2019 Q1	$71K	Hold	1,854	–	–	﹤0.01%	1529
2018 Q4	$37K	Buy	+1,854	New	+$55.6K	﹤0.01%	1720
2018 Q3	–	Sell	-171	Closed	-$10K	–	1722
2018 Q2	$10K	Buy	171 +25	+17%	+$1.45K	﹤0.01%	1906
2018 Q1	$14K	Hold	146	–	–	﹤0.01%	2082
2017 Q4	$14K	Buy	146 +46	+46%	+$5.15K	﹤0.01%	2082
2017 Q3	$11K	Hold	100	–	–	﹤0.01%	2159
2017 Q2	$3K	Hold	100	–	–	﹤0.01%	2411
2017 Q1	$3K	Hold	100	–	–	﹤0.01%	2411
2016 Q4	$3K	Hold	100	–	–	﹤0.01%	2311
2016 Q3	$6K	Hold	100	–	–	﹤0.01%	2234
2016 Q2	$2K	Hold	100	–	–	﹤0.01%	2406
2016 Q1	$2K	Hold	100	–	–	﹤0.01%	2410
2015 Q4	$7K	Hold	100	–	–	﹤0.01%	2167
2015 Q3	$7K	Hold	100	–	–	﹤0.01%	2207
2015 Q2	$11K	Hold	100	–	–	﹤0.01%	2085
2015 Q1	$23K	Hold	100	–	–	﹤0.01%	1903
2014 Q4	$18K	Buy	+100	New	+$22.2K	﹤0.01%	2049

Other funds holding PBYI

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Glenmede Trust's PBYI Position: Q4 2020 in Review

Glenmede Trust sold out of Puma Biotechnology (PBYI) in Q4 2020, closing a stake of 928 shares — an estimated $9K sold.

Glenmede Trust first reported a position in PBYI in Q4 2014 and held it in 23 quarters. The position peaked at $71K in Q1 2019. 123 funds tracked by Wall St. Rank hold PBYI as of Q4 2020.

Glenmede Trust reported no remaining Puma Biotechnology position as of Q4 2020 after selling out during the quarter.
Glenmede Trust sold 928 Puma Biotechnology shares in Q4 2020, an estimated $9K.
Glenmede Trust first reported a position in Puma Biotechnology in Q4 2014 and held it in 23 quarters.
Glenmede Trust's Puma Biotechnology position peaked at $71K in Q1 2019.
123 funds tracked by Wall St. Rank held Puma Biotechnology as of Q4 2020.

Based on Glenmede Trust's 13F filing for Q4 2020, filed 16 Feb 2021.